Patent · US Active

Method for determining optimum intraocular locations for drug delivery systems

US8571802B2 · kind B2 · utility

28Cited by
19References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 30, 2007
Grant dateOct 29, 2013
Priority date
Expiry dateAug 16, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for determining the optimum location for placement of an intraocular implant containing used to treat an ocular condition, particularly implants comprised of a biodegradable polymer and a therapeutic agent for the treatment of retinal tissue.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.